The European sold production of medicaments containing hormones but not antibiotics shows distinct country variations. Denmark leads with a significant share, though experiencing a slight decline in 2023. Belgium and Germany witnessed growth, with Belgium showing notable improvement. Conversely, Italy and Greece faced significant reductions. The Netherlands and Spain exhibited robust increases, indicating rising production capabilities. Minor contributors like Portugal, Romania, and Macedonia also demonstrated growth, contrasting with Spain's substantial year-on-year increase. Austria and Greece faced declines, signaling possible market challenges.
Future trends to watch include:
- Denmark's market maintaining its leadership despite slight declines.
- Belgium and Germany potentially gaining prominence due to consistent growth.
- Expansion opportunities for countries like Spain and the Netherlands, capitalizing on their positive trajectories.
- Monitoring the declining trends in Italy and Greece for potential market shifts.
- The growth of minor players indicating increasing competition and innovation in the sector.
Top countries in Sold Production of Medicaments Containing Hormones But Not Antibiotics Share by Country (Euros)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Denmark | 61.72 | 2023 | +2.47% | -1.93% | View data |
| 2 | 2 Belgium | 18.07 | 2023 | +47.59% | +8.13% | View data |
| 3 | 3 Germany | 10.16 | 2023 | +2% | +4.72% | View data |
| 4 | 4 Italy | 2.85 | 2023 | -2.09% | -21.21% | View data |
| 5 | 5 Sweden | 2.13 | 2023 | +4.96% | View data | |
| 6 | 6 Spain | 2.08 | 2023 | +9.88% | +12.3% | View data |
| 7 | 7 Netherlands | 1.03 | 2023 | +2.81% | +19.11% | View data |
| 8 | 8 Hungary | 0.81 | 2023 | +3.14% | +1.05% | View data |
| 9 | 9 Croatia | 0.71 | 2023 | +4.42% | +6.35% | View data |
| 10 | 10 Portugal | 0.34 | 2023 | +5.41% | +13.14% | View data |
